Through clinical research and field application, Abacus is focused on activating health behavior change, improving health outcomes, and lowering healthcare costs using incentives, communications, and technology.
Over the past thirty years, Abacus has been awarded more than $8 million in federal funding from Small Business Innovation Research grants from multiple divisions of the federal government including the National Institutes on Health and the Agency for Healthcare Research and Quality. Those grants primarily funded the research and development of evidence-based, consumer decision-support eHealth tools that are effective in improving health outcomes.
Areas of focus include the effects of home monitoring of blood pressure as a way to improve outcomes for higher risk populations such as kidney transplant recipients and the identification of one’s Lung Age as a means for increasing awareness around the proper management of asthma and ill effects of smoking. Another study called the “HeartAge Study – Using E-health to Improve Cholesterol Management in Primary Care Practice.” Contact us for more information.
Earlier research and programs were designed to reduce the cost of pharmaceuticals as well as increase patient adherence to medications needed to appropriately manage their condition.
The HeartAge tool, developed with funding from the National Heart Lung and Blood Institute (NHLBI), can be used to make members aware of their risk for CVD, understand risk factors, and motivate behavior change. Co-Founder David Ahern is a co-author.
Abacus strives to work with each employer to develop a program that will best benefit them and their unique population. For more information about any of our tools, programs, and services, please contact us.
Please contact us to learn more about past and current Abacus research and how it influences the products and services we offer today.